As summarized in Table 2, the expression level of IGF2BP3 was significantly associated with multiple GC characteristics, including lymph node involvement (p = 0.016) and tumor-node-metastasis (TNM) staging (p = 0.028). This evidence concerns the gene IGF2BP3 and gastric cancer.